291 related articles for article (PubMed ID: 25269563)
1. Melatonin and renal protection: novel perspectives from animal experiments and human studies (review).
Hrenak J; Paulis L; Repova K; Aziriova S; Nagtegaal EJ; Reiter RJ; Simko F
Curr Pharm Des; 2015; 21(7):936-49. PubMed ID: 25269563
[TBL] [Abstract][Full Text] [Related]
2. The roles of melatonin on kidney injury in obese and diabetic conditions.
Promsan S; Lungkaphin A
Biofactors; 2020 Jul; 46(4):531-549. PubMed ID: 32449276
[TBL] [Abstract][Full Text] [Related]
3. Melatonin Treatment in Kidney Diseases.
Markowska M; Niemczyk S; Romejko K
Cells; 2023 Mar; 12(6):. PubMed ID: 36980179
[TBL] [Abstract][Full Text] [Related]
4. Melatonin ameliorates oxidative stress, inflammation, proteinuria, and progression of renal damage in rats with renal mass reduction.
Quiroz Y; Ferrebuz A; Romero F; Vaziri ND; Rodriguez-Iturbe B
Am J Physiol Renal Physiol; 2008 Feb; 294(2):F336-44. PubMed ID: 18077597
[TBL] [Abstract][Full Text] [Related]
5. The smell of renal protection against chronic kidney disease: Hydrogen sulfide offers a potential stinky remedy.
Dugbartey GJ
Pharmacol Rep; 2018 Apr; 70(2):196-205. PubMed ID: 29471067
[TBL] [Abstract][Full Text] [Related]
6. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
[TBL] [Abstract][Full Text] [Related]
7. Melatonin and Kidney Health: From Fetal Stage to Later Life.
Tang KS; Ho CY; Hsu CN; Tain YL
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175813
[TBL] [Abstract][Full Text] [Related]
8. Melatonin protects chronic kidney disease mesenchymal stem cells against senescence via PrP
Han YS; Kim SM; Lee JH; Jung SK; Noh H; Lee SH
J Pineal Res; 2019 Jan; 66(1):e12535. PubMed ID: 30372554
[TBL] [Abstract][Full Text] [Related]
9. Effects of Single and Combined Losartan and Tempol Treatments on Oxidative Stress, Kidney Structure and Function in Spontaneously Hypertensive Rats with Early Course of Proteinuric Nephropathy.
Karanovic D; Grujic-Milanovic J; Miloradovic Z; Ivanov M; Jovovic D; Vajic UJ; Zivotic M; Markovic-Lipkovski J; Mihailovic-Stanojevic N
PLoS One; 2016; 11(8):e0161706. PubMed ID: 27560781
[TBL] [Abstract][Full Text] [Related]
10. The role of melatonin treatment in chronic kidney disease.
Russcher M; Koch B; Nagtegaal E; van der Putten K; ter Wee P; Gaillard C
Front Biosci (Landmark Ed); 2012 Jun; 17(7):2644-56. PubMed ID: 22652802
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent deleterious and salutary actions of the Nrf2 inducer dh404 in chronic kidney disease.
Vaziri ND; Liu S; Farzaneh SH; Nazertehrani S; Khazaeli M; Zhao YY
Free Radic Biol Med; 2015 Sep; 86():374-81. PubMed ID: 25930007
[TBL] [Abstract][Full Text] [Related]
12. Melatonin ameliorates intrarenal renin-angiotensin system in a 5/6 nephrectomy rat model.
Ishigaki S; Ohashi N; Matsuyama T; Isobe S; Tsuji N; Iwakura T; Fujikura T; Tsuji T; Kato A; Miyajima H; Yasuda H
Clin Exp Nephrol; 2018 Jun; 22(3):539-549. PubMed ID: 29159527
[TBL] [Abstract][Full Text] [Related]
13. Melatonin as an antioxidant: under promises but over delivers.
Reiter RJ; Mayo JC; Tan DX; Sainz RM; Alatorre-Jimenez M; Qin L
J Pineal Res; 2016 Oct; 61(3):253-78. PubMed ID: 27500468
[TBL] [Abstract][Full Text] [Related]
14. Targeting Nrf2 in Protection Against Renal Disease.
Guerrero-Hue M; Farre-Alins V; Palomino-Antolin A; Parada E; Rubio-Navarro A; Egido J; Egea J; Moreno JA
Curr Med Chem; 2017; 24(33):3583-3605. PubMed ID: 28494744
[TBL] [Abstract][Full Text] [Related]
15. Impaired endogenous nighttime melatonin secretion relates to intrarenal renin-angiotensin system activation and renal damage in patients with chronic kidney disease.
Ishigaki S; Ohashi N; Isobe S; Tsuji N; Iwakura T; Ono M; Sakao Y; Tsuji T; Kato A; Miyajima H; Yasuda H
Clin Exp Nephrol; 2016 Dec; 20(6):878-884. PubMed ID: 26743744
[TBL] [Abstract][Full Text] [Related]
16. The Role of Melatonin in Chronic Kidney Disease and Its Associated Risk Factors: A New Tool in Our Arsenal?
Theofilis P; Vordoni A; Kalaitzidis RG
Am J Nephrol; 2022; 53(7):565-574. PubMed ID: 35767942
[TBL] [Abstract][Full Text] [Related]
17. Medical implications of melatonin: receptor-mediated and receptor-independent actions.
Reiter RJ; Tan DX; Manchester LC; Pilar Terron M; Flores LJ; Koppisepi S
Adv Med Sci; 2007; 52():11-28. PubMed ID: 18217386
[TBL] [Abstract][Full Text] [Related]
18. Possible benefits of exogenous melatonin for individuals on dialysis: a narrative review on potential mechanisms and clinical implications.
Movahhed SMM
Naunyn Schmiedebergs Arch Pharmacol; 2021 Aug; 394(8):1599-1611. PubMed ID: 34097094
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of melatonin in targeting molecular pathways of organ fibrosis.
Hosseinzadeh A; Pourhanifeh MH; Amiri S; Sheibani M; Irilouzadian R; Reiter RJ; Mehrzadi S
Pharmacol Rep; 2024 Feb; 76(1):25-50. PubMed ID: 37995089
[TBL] [Abstract][Full Text] [Related]
20. A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and new perspectives.
Mauriz JL; Collado PS; Veneroso C; Reiter RJ; González-Gallego J
J Pineal Res; 2013 Jan; 54(1):1-14. PubMed ID: 22725668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
